Literature DB >> 22447375

MALT Lymphoma of the Gastric Remnant After Roux-en-Y Gastric Bypass.

Ahmed Jawad1, Allan H Bar2, Demetri Merianos3, Jing Zhou4.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22447375     DOI： 10.1007/s12029-012-9386-1

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  32 in total

1.  Effects of bile reflux and intragastric microflora changes on lesions of remnant gastric mucosa after gastric operation.

Authors:  Chao Zhang; Zhan-Kui Liu; Pei-Wu Yu
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

2.  Cancer in the excluded stomach 4 years after gastric bypass.

Authors:  Deborah A Corsini; Celso A M Simoneti; Gisele Moreira; Sizenando E Lima; Arthur B Garrido
Journal:  Obes Surg       Date:  2006-07       Impact factor: 4.129

3.  Primary gastrointestinal non-Hodgkin's lymphoma: clinicopathological and prognostic analysis.

Authors:  Tong Wang; Wei Gui; Quanliang Shen
Journal:  Med Oncol       Date:  2009-06-30       Impact factor: 3.064

4.  Report of two cases of gastric cancer after bariatric surgery: lymphoma of the bypassed stomach after Roux-en-Y gastric bypass and gastrointestinal stromal tumor (GIST) after vertical banded gastroplasty.

Authors:  Arnaud de Roover; Olivier Detry; Laurence de Leval; Carla Coimbra; Claude Desaive; Pierre Honoré; Michel Meurisse
Journal:  Obes Surg       Date:  2006-07       Impact factor: 4.129

5.  Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis.

Authors:  T Radaszkiewicz; B Dragosics; P Bauer
Journal:  Gastroenterology       Date:  1992-05       Impact factor: 22.682

6.  Treatment outcome of mucosa-associated lymphoid tissue/marginal zone non-Hodgkin's lymphoma.

Authors:  Stacie Hitchcock; Andrea K Ng; David C Fisher; Barbara Silver; M Patricia Bernardo; David M Dorfman; Peter M Mauch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-03-15       Impact factor: 7.038

7.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

8.  Laparoscopic resectional gastric bypass in patients with morbid obesity: experience on 112 consecutive patients.

Authors:  Italo Braghetto; Attila Csendes; Owen Korn; Luis Gutierrez; Luis Brunet; Enrique Lanzarini; Maher Mushle; Héctor Valladares; Jorge Rojas
Journal:  J Gastrointest Surg       Date:  2011-01       Impact factor: 3.452

9.  Primary gastric lymphoma in clinical practice 1973-1992.

Authors:  A F Muller; A Maloney; D Jenkins; F Dowling; P Smith; E M Bessell; P J Toghill
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

10.  Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group.

Authors:  E Bayerdörffer; A Neubauer; B Rudolph; C Thiede; N Lehn; S Eidt; M Stolte
Journal:  Lancet       Date:  1995-06-24       Impact factor: 79.321
View more
  3 in total

Review 1.  Gastro-Intestinal Tract Cancers Following Bariatric Surgery: a Narrative Review.

Authors:  Reza Ebrahimi; Mohammad Kermansaravi; Alireza Khalaj; Foolad Eghbali; Ali Mousavi; Abdolreza Pazouki
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

Review 2.  Reconstruction options following pancreaticoduodenectomy after Roux-en-Y gastric bypass: a systematic review.

Authors:  William F Morano; Mohammad F Shaikh; Elizabeth M Gleeson; Alvaro Galvez; Marian Khalili; John Lieb; Elizabeth P Renza-Stingone; Wilbur B Bowne
Journal:  World J Surg Oncol       Date:  2018-08-13       Impact factor: 2.754

3.  Helicobacter pylori-negative extra-nodal marginal zone B-cell lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) type following Roux-en-Y Gastric Bypass (RYGB).

Authors:  Zachary R Eagle; Francis Essien; Kimberly Zibert; Charles Miller; Melissa Van Dellen; Rina Eden; Ross Pinson
Journal:  Clin Case Rep       Date:  2022-01-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.